Literature DB >> 15177181

Spontaneous and cisplatin-induced recombination in Escherichia coli.

Anetta Nowosielska1, Melissa A Calmann, Zoran Zdraveski, John M Essigmann, M G Marinus.   

Abstract

To measure cisplatin (cis-diaminodichloroplatinum(II))-induced recombination, we have used a qualitative intrachromosomal assay utilizing duplicate inactive lac operons containing non-overlapping deletions and selection for Lac+ recombinants. The two operons are separated by one Mb and conversion of one of them yields the Lac+ phenotype. Lac+ formation for both spontaneous and cisplatin-induced recombination requires the products of the recA, recBC, ruvA, ruvB, ruvC, priA and polA genes. Inactivation of the recF, recO, recR and recJ genes decreased cisplatin-induced, but not spontaneous, recombination. The dependence on PriA and RecBC suggests that recombination is induced following stalling or collapse of replication forks at DNA lesions to form double strand breaks. The lack of recombination induction by trans-DDP suggests that the recombinogenic lesions for cisplatin are purine-purine intrastrand crosslinks.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15177181     DOI: 10.1016/j.dnarep.2004.02.009

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  10 in total

1.  Pharmacologic inhibition of ATR and ATM offers clinically important distinctions to enhancing platinum or radiation response in ovarian, endometrial, and cervical cancer cells.

Authors:  Pang-ning Teng; Nicholas W Bateman; Kathleen M Darcy; Chad A Hamilton; George Larry Maxwell; Christopher J Bakkenist; Thomas P Conrads
Journal:  Gynecol Oncol       Date:  2015-01-02       Impact factor: 5.482

2.  Determination of hypersensitivity to genotoxic agents among Escherichia coli single gene knockout mutants.

Authors:  Elinne Becket; Frank Chen; Cindy Tamae; Jeffrey H Miller
Journal:  DNA Repair (Amst)       Date:  2010-07-31

3.  Differential effects of cisplatin and MNNG on dna mutants of Escherichia coli.

Authors:  Melissa A Calmann; M G Marinus
Journal:  Mutat Res       Date:  2005-10-15       Impact factor: 2.433

4.  MutS homologue hMSH5: role in cisplatin-induced DNA damage response.

Authors:  Joshua D Tompkins; Xiling Wu; Chengtao Her
Journal:  Mol Cancer       Date:  2012-03-08       Impact factor: 27.401

5.  MSH2 missense mutations alter cisplatin cytotoxicity and promote cisplatin-induced genome instability.

Authors:  Jill E Clodfelter; Michael B Gentry; Karin Drotschmann
Journal:  Nucleic Acids Res       Date:  2005-06-09       Impact factor: 16.971

6.  Homologous recombination prevents methylation-induced toxicity in Escherichia coli.

Authors:  Anetta Nowosielska; Stephen A Smith; Bevin P Engelward; M G Marinus
Journal:  Nucleic Acids Res       Date:  2006-05-02       Impact factor: 16.971

7.  Separation of mutation avoidance and antirecombination functions in an Escherichia coli mutS mutant.

Authors:  Melissa A Calmann; Anetta Nowosielska; M G Marinus
Journal:  Nucleic Acids Res       Date:  2005-02-24       Impact factor: 16.971

8.  MutS inhibits RecA-mediated strand transfer with methylated DNA substrates.

Authors:  Melissa A Calmann; James E Evans; M G Marinus
Journal:  Nucleic Acids Res       Date:  2005-06-22       Impact factor: 16.971

9.  MutS homologue hMSH5: recombinational DSB repair and non-synonymous polymorphic variants.

Authors:  Xiling Wu; Yang Xu; Katey Feng; Joshua D Tompkins; Chengtao Her
Journal:  PLoS One       Date:  2013-09-04       Impact factor: 3.240

10.  MutS Homologues hMSH4 and hMSH5: Genetic Variations, Functions, and Implications in Human Diseases.

Authors:  Nicole Clark; Xiling Wu; Chengtao Her
Journal:  Curr Genomics       Date:  2013-04       Impact factor: 2.236

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.